by Admin | Mar 2, 2022 | CME INDIA Repository
CME INDIA Presentation by Dr. N.K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Adding a new patient profile in whom we can start empagliflozin in hospital. Starting SGLT2 inhibitors as soon as in...
by Admin | Sep 15, 2021 | CME INDIA Repository
CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director – Diabetes and Heart Research Centre, Dhanbad; Editor – CME INDIA. Black hole of cardiology, the HFpEF gets an efficacious, disease modifying treatment – NNT (Number needed to treat) of 9....
